- Vouliez-vous dire
- arise, kevin k
Résultats de la recherche - 28 results
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksAbstract
Ricardo; Delforge, Marie-Luce; Vael, Carl; Berckmans, Lynsey; Selhorst, Philippe; Ariën, Kevin K.; Van Dooren, Sonia; Hinckel, Bruno; Imamura, Hideo; Janssen, Toon; Caljon, Ben; Soetens, Oriane; Piérard, ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx
Vanhoutte, Greetje; Peeters, Bart; Raats, Silke; Massen, Isolde Van der; De Keersmaecker, Sven; Debie, Yana; Huizing, Manon; Pannus, Pieter; Neven, Kristof Y.; Ariën, Kevin K.; Martens, Geert A.; Bulcke, Marc ...
Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort studyObjectivesDesignSettingParticipantsOutcome measuresResultsConclusionsTrial registration number
Ines Kabouche; Ariën, Kevin K; I Desombere; Els Duysburgh Source: BMJ Open, Volume 11, Issue 6 (2021) Health Topics: SARS-CoV-2 Service: Infections liées aux soins et antibiorésistance Zorginfecties en ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Lemy, Anne; Maria Goossens; I Desombere; Michiels, Johan; Vandevenne, Marylène; Heyndrickx, Leo; Ariën, Kevin K; Matagne, André; Ackerman, Margaret E; Le Moine, Alain; Marchant, Arnaud Source: Am ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; Desombere, Isabelle; Ariën, Kevin K; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Keywords: Adult ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
Verbrugghe, Mathieu; Van Loon, Nele; Dierick, Katelijne; Matagne, André; I Desombere; Ariën, Kevin K.; Marchant, Arnaud; Maria Goossens Source: Vaccine, Volume 41, Issue 17 (2023) Health Topics: Health and ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Goossens; Pieter Pannus; Ariën, Kevin K; Sébastien Anguille; Annelies Janssens; Hans Prenen; Evelien L J Smits; Christof Vulsteke; Eva Lion; Peeters, ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Publication Type: Peer reviewed scientific article Authors: Frédéric Baron; Lorenzo Canti; Ariën, Kevin K; Delphine Kemlin; I Desombere; Margaux Gerbaux; Pieter Pannus; Yves Beguin; Arnaud Marchant; ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; Sven De Keersmaecker; Yana Debie; Manon Huizing; Pieter Pannus; Kristof Y Neven; Ariën, Kevin K; Geert A Martens; Marc Van den Bulcke; Ella Roelant; ...